Page last updated: 2024-09-03

cholestyramine resin and ursocholic acid

cholestyramine resin has been researched along with ursocholic acid in 1 studies

Compound Research Comparison

Studies (cholestyramine resin)	Trials (cholestyramine resin)	Recent Studies (post-2010) (cholestyramine resin)	Studies (ursocholic acid)	Trials (ursocholic acid)	Recent Studies (post-2010) (ursocholic acid)
2,669	342	190	36	4	2

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Batta, AK; Salen, G; Tint, GS	1

Trials

1 trial(s) available for cholestyramine resin and ursocholic acid

Article	Year
Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis. Metabolism: clinical and experimental, 2004, Volume: 53, Issue:5 Topics: Adult; Anticholesteremic Agents; Bile; Bile Acids and Salts; Case-Control Studies; Chenodeoxycholic Acid; Cholestanols; Cholesterol; Cholestyramine Resin; Cholic Acids; Homozygote; Humans; Lovastatin; Male; Middle Aged; Ursodeoxycholic Acid; Xanthomatosis, Cerebrotendinous	2004

Article

Year

Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis.

Metabolism: clinical and experimental, 2004, Volume: 53, Issue:5

Topics: Adult; Anticholesteremic Agents; Bile; Bile Acids and Salts; Case-Control Studies; Chenodeoxycholic Acid; Cholestanols; Cholesterol; Cholestyramine Resin; Cholic Acids; Homozygote; Humans; Lovastatin; Male; Middle Aged; Ursodeoxycholic Acid; Xanthomatosis, Cerebrotendinous

2004